Welcome to Paid Research Studies




  • Conditions:   Gallbladder Diseases;   Healthy
    Intervention:   Other: Benigh gallbladder diseases
    Sponsor:   Tongji Hospital
    Not yet recruiting

  • Condition:   Gallbladder Carcinoma
    Interventions:   Drug: Apatinib;   Drug: Tegafur
    Sponsor:   Eastern Hepatobiliary Surgery Hospital
    Recruiting

  • Condition:   Gall Bladder Cancers
    Interventions:   Drug: Gemcitabine;   Drug: Cisplatin;   Radiation: Chemoradiation;   Procedure: PETCECT;   Procedure: Laparoscopy
    Sponsor:   Tata Memorial Hospital
    Recruiting

  • Condition:   Gall Bladder Disease
    Intervention:  
    Sponsor:   Assiut University
    Not yet recruiting

  • Conditions:   Proteinosis;   Gallbladder Carcinoma
    Intervention:  
    Sponsors:   liu yingbin;   First Hospital of Jilin University;   Shanghai Zhongshan Hosiptal;   First Affiliated Hospital Bengbu Medical College;   Second Affiliated Hospital of Nanchang University;   The Affiliated Hospital of Inner Mongolia Medical University;   First Affiliated Hospital of Xinjiang Medical University;   The First Affiliated Hospital of Shanxi Medical University;   The affiliated hospital of Jining medical college;   The Affiliated Hospital of Tianjin Medical University;   The first affiliated hospital of Zhongshan university
    Recruiting

  • Conditions:   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Gallbladder Cancer
    Intervention:   Biological: mutation and signal pathway activation status analysis Drug: FORFIRINOX
    Sponsors:   Shanghai Jiao Tong University School of Medicine;   Ruijin Hospital;   RenJi Hospital;   Eastern Hepatobiliary Surgery Hospital;   Huashan Hospital
    Recruiting

  • Conditions:   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Gallbladder Cancer
    Interventions:   Biological: conventional chemotherapy(FORFIRINOX) combined with target agents;   Biological: conventional chemotherapy(FORFIRINOX)
    Sponsors:   Shanghai Jiao Tong University School of Medicine;   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine;   Ruijin Hospital;   RenJi Hospital;   Eastern Hepatobiliary Surgery Hospital;   Huashan Hospital
    Recruiting

  • Conditions:   Incidental Gallbladder Carcinoma;   Biliary Tract Cancer
    Interventions:   Drug: Gemcitabine;   Drug: Cisplatin;   Procedure: Oncologically radical margin-free (R0) resection;   Drug: Adjuvant chemotherapy
    Sponsors:   Krankenhaus Nordwest;   German Research Foundation
    Not yet recruiting

  • Conditions:   Pancreas Cancer;   Cholangiocarcinoma;   Gallbladder Cancer
    Intervention:   Other: Measurement of triceps skinfold thickness
    Sponsor:   Samsung Medical Center
    Recruiting

  • Conditions:   Stage I Gallbladder Cancer AJCC v8;   Stage II Gallbladder Cancer AJCC v8;   Stage IIA Gallbladder Cancer AJCC v8;   Stage IIB Gallbladder Cancer AJCC v8;   Stage III Gallbladder Cancer AJCC v8;   Stage IIIA Gallbladder Cancer AJCC v8;   Stage IIIB Gallbladder Cancer AJCC v8
    Interventions:   Drug: Capecitabine;   Drug: Cisplatin;   Drug: Gemcitabine
    Sponsor:   Emory University
    Recruiting

  • Condition:   Gallbladder Diseases
    Interventions:   Drug: Sugammadex Injectable Product;   Drug: Neostigmine Injectable Product
    Sponsor:   Ajou University School of Medicine
    Recruiting

  • Condition:   Gallbladder Diseases
    Intervention:  
    Sponsor:   University of Illinois at Chicago
    Recruiting

  • Conditions:   Cholangiocarcinoma;   Gall Bladder Carcinoma
    Interventions:   Drug: Gemcitabine;   Drug: Cisplatin;   Drug: Capecitabine
    Sponsors:   Universitätsklinikum Hamburg-Eppendorf;   Deutsche Krebshilfe e.V., Bonn (Germany);   medac GmbH;   Cancer Research UK;   Australasian Gastro-Intestinal Trials Group;   Dutch Hepatocellular & Cholangiocarcinoma Group (DHCG)
    Recruiting

  • Conditions:   Biliary Tract Cancer;   Cholangiocarcinoma;   Gallbladder Cancer
    Intervention:   Drug: M7824
    Sponsors:   EMD Serono Research & Development Institute, Inc.;   Merck KGaA, Darmstadt, Germany
    Recruiting

  • Conditions:   Extrahepatic Bile Duct Adenocarcinoma, Biliary Type;   Gallbladder Adenocarcinoma, Biliary Type;   Metastatic Pancreatic Adenocarcinoma;   Recurrent Cholangiocarcinoma;   Recurrent Gallbladder Carcinoma;   Recurrent Hepatocellular Carcinoma;   Recurrent Intrahepatic Cholangiocarcinoma;   Recurrent Pancreatic Carcinoma;   Stage III Gallbladder Cancer AJCC V7;   Stage III Hepatocellular Carcinoma AJCC v7;   Stage III Intrahepatic Cholangiocarcinoma AJCC v7;   Stage III Pancreatic Cancer AJCC v6 and v7;   Stage IIIA Gallbladder Cancer AJCC v7;   Stage IIIA Hepatocellular Carcinoma AJCC v7;   Stage IIIB Gallbladder Cancer AJCC v7;   Stage IIIB Hepatocellular Carcinoma AJCC v7;   Stage IIIC Hepatocellular Carcinoma AJCC v7;   Stage IV Gallbladder Cancer AJCC v7;   Stage IV Hepatocellular Carcinoma AJCC v7;   Stage IV Pancreatic Cancer AJCC v6 and v7;   Stage IVA Gallbladder Cancer AJCC v7;   Stage IVA Hepatocellular Carcinoma AJCC v7;   Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7;   Stage IVB Gallbladder Cancer AJCC v7;   Stage IVB Hepatocellular Carcinoma AJCC v7;   Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7;   Unresectable Gallbladder Carcinoma;   Unresectable Pancreatic Carcinoma
    Interventions:   Biological: Durvalumab;   Drug: Guadecitabine
    Sponsors:   University of Southern California;   National Cancer Institute (NCI);   Van Andel Research Institute
    Recruiting

  • Condition:   Cholecystitis, Acute
    Intervention:   Device: AXIOS
    Sponsor:   Boston Scientific Corporation
    Not yet recruiting

  • Conditions:   Cholangiocarcinoma Non-resectable;   Cholangiocarcinoma Metastatic;   Cholangiocarcinoma of the Gallbladder;   Cholangiocarcinoma Advanced
    Interventions:   Drug: nal-IRI;   Drug: 5-FU;   Drug: leucovorin
    Sponsors:   AIO-Studien-gGmbH;   SERVIER (Shire)
    Recruiting

  • Condition:   Cholangiocarcinoma, Gallbladder Cancer, Pancreatic Cancer
    Interventions:   Device: Radiofrequency ablation with stenting;   Device: stenting
    Sponsor:   Yonsei University
    Recruiting

  • Conditions:   Gallbladder Cancer;   Nutritional and Metabolic Diseases
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Hyperemesis Gravidarum;   Pregnancy Related
    Intervention:  
    Sponsor:   Müge Keskin
    Recruiting

  • Conditions:   Cholelithiasis;   Gall Stone;   Gall Bladder Disease
    Interventions:   Diagnostic Test: Bile test;   Diagnostic Test: Blood test;   Diagnostic Test: Gall stone study;   Diagnostic Test: Microbiological bile test
    Sponsor:   Hospital Son Espases
    Not yet recruiting

  • Condition:   Pain, Acute
    Interventions:   Drug: the infiltration group;   Drug: the control group
    Sponsor:   Alaa Mazy
    Recruiting

  • Conditions:   Bile Duct; Obstruction, With Calculus;   Choledocholithiasis
    Intervention:   Procedure: Gall bladder transmural drainage with LAMS
    Sponsors:   Hospital del Río Hortega;   Hospital Universitario Ramon y Cajal;   Hospital General Universitario de Alicante
    Not yet recruiting

  • Conditions:   Cholangiocarcinoma;   Gall Bladder Carcinoma
    Interventions:   Drug: Gemcitabine;   Drug: Capecitabine
    Sponsor:   Tianjin Medical University Cancer Institute and Hospital
    Recruiting

  • Conditions:   Fluorenscent Image Guided Surgery;   Indocyanide Green
    Interventions:   Procedure: ICG GB;   Procedure: ICG IV;   Procedure: LC conventional;   Procedure: LC conventional and IOC
    Sponsor:   Chang Gung Memorial Hospital
    Recruiting

  • Condition:   Acute Cholecystitis
    Interventions:   Procedure: EUS-guided gallbladder drainage;   Procedure: Non EUS-guided gallbladder drainage
    Sponsor:   Instituto Ecuatoriano de Enfermedades Digestivas
    Recruiting

  • Conditions:   Appendix;   Appendectomy;   Appendiceal Neoplasms;   Gallbladder;   Cholecystectomy;   Gallbladder Neoplasms
    Interventions:   Other: Inspection and palpation of the appendix;   Other: Inspection and palpation of the gallbladder
    Sponsors:   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   ZonMw: The Netherlands Organisation for Health Research and Development
    Recruiting

  • Conditions:   Cholangiocarcinoma;   Gallbladder Cancer;   Pancreatic Cancer;   HCC;   AOV Cancer
    Interventions:   Procedure: side by side;   Procedure: stent in stent
    Sponsor:   Yonsei University
    Recruiting

  • Conditions:   Cholecystitis;   Cholecystolithiasis;   Polyps Gallbladder;   Adenomyosis of Gallbladder
    Intervention:   Procedure: drainage tube
    Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
    Recruiting

  • Condition:   Biliary Disease
    Interventions:   Drug: Transversus abdominis plane block;   Drug: local infiltration anesthesia;   Drug: Intravenous patient controlled analgesia
    Sponsor:   Diskapi Yildirim Beyazit Education and Research Hospital
    Recruiting

  • Conditions:   Cholangiocarcinoma;   Liver and Intrahepatic Bile Duct Carcinoma;   Stage III Gallbladder Cancer AJCC v7;   Stage III Intrahepatic Cholangiocarcinoma AJCC v7;   Stage IIIA Gallbladder Cancer AJCC v7;   Stage IIIB Gallbladder Cancer AJCC v7;   Stage IV Gallbladder Cancer AJCC v7;   Stage IVA Gallbladder Cancer AJCC v7;   Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7;   Stage IVB Gallbladder Cancer AJCC v7;   Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7;   Unresectable Gallbladder Carcinoma
    Interventions:   Other: Laboratory Biomarker Analysis;   Biological: Ramucirumab
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Biliary Tract Neoplasms;   Cholangiocarcinoma;   Bile Duct Cancer;   Liver Cancer;   Gallbladder Cancer
    Interventions:   Biological: Pembrolizumab (MK-3475);   Drug: Oxaliplatin;   Drug: Capecitabine
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Choledocholithiasis
    Interventions:   Procedure: endoscopic ultrasound;   Procedure: intraoperative cholangiography;   Procedure: ERCP;   Device: Ultrasound endoscope
    Sponsor:   Vilnius University
    Recruiting

  • Conditions:   Stage III Distal Bile Duct Cancer AJCC v8;   Stage III Gallbladder Cancer AJCC v8;   Stage III Intrahepatic Cholangiocarcinoma AJCC v8;   Stage IIIA Distal Bile Duct Cancer AJCC v8;   Stage IIIA Gallbladder Cancer AJCC v8;   Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8;   Stage IIIB Distal Bile Duct Cancer AJCC v8;   Stage IIIB Gallbladder Cancer AJCC v8;   Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8;   Stage IV Distal Bile Duct Cancer AJCC v8;   Stage IV Gallbladder Cancer AJCC v8;   Stage IV Intrahepatic Cholangiocarcinoma AJCC v8;   Stage IVA Gallbladder Cancer AJCC v8;   Stage IVB Gallbladder Cancer AJCC v8;   Unresectable Extrahepatic Bile Duct Carcinoma;   Unresectable Gallbladder Carcinoma;   Unresectable Intrahepatic Cholangiocarcinoma
    Interventions:   Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Drug: Nab-paclitaxel
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   ERCP;   Biliary Disease Tract;   Biliary Disease
    Intervention:   Procedure: Needle knife fistulotomy
    Sponsor:   Queen's University
    Recruiting

  • Conditions:   Head and Neck Squamous Cell Carcinoma;   Metastatic Pancreatic Adenocarcinoma;   Non-Resectable Cholangiocarcinoma;   Pancreatic Adenocarcinoma;   Recurrent Gallbladder Carcinoma;   Recurrent Non-Small Cell Lung Carcinoma;   Stage III Pancreatic Cancer;   Stage IIIA Gallbladder Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Gallbladder Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Gallbladder Cancer;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Pancreatic Cancer;   Unresectable Gallbladder Carcinoma;   Unresectable Pancreatic Cancer
    Interventions:   Drug: Cisplatin;   Drug: Docetaxel;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation;   Other: Pharmacological Study;   Biological: Recombinant EphB4-HSA Fusion Protein
    Sponsors:   University of Southern California;   National Cancer Institute (NCI);   Vasgene Therapeutics, Inc
    Recruiting

  • Conditions:   Radiation Therapy;   Cancer;   Cancer of Anus;   Cancer of Bladder;   Cancer of Cervix;   Cancer of Colon;   Cancer of Rectum;   Cancer of Esophagus;   Cancer of Gallbladder;   Cancer of Liver;   Cancer of Ovary;   Cancer of Pancreas;   Cancer of Prostate;   Cancer of Kidney and Renal Pelvis;   Cancer of Stomach;   Cancer of Testis;   Cancer of Uterus;   Cancer of Uterus and Cervix;   Cancer of Kidney
    Intervention:  
    Sponsors:   DxTerity Diagnostics;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Tumor, Solid;   Gall Bladder Cancer;   Cervical Cancer;   Colorectal Cancer;   Gastric Cancer;   Pancreatic Cancer;   Clear Cell Renal Cell Carcinoma
    Intervention:   Drug: Andes-1537 for Injection
    Sponsor:   Andes Biotechnologies
    Recruiting

  • Conditions:   Liver Cancer;   Pancreatic Cancer;   Gastric Cancer;   Esophageal Cancer;   Colo-rectal Cancer;   Gall Bladder Cancer;   Biliary Tract Cancer
    Interventions:   Drug: Fluorouracil;   Drug: Lederfolin;   Drug: Oxaliplatin;   Drug: Irinotecan;   Drug: Docetaxel;   Drug: Cisplatin;   Drug: Epirubicin;   Drug: Gemcitabine;   Drug: Nab paclitaxel
    Sponsors:   University of Pisa;   Azienda Ospedaliero, Universitaria Pisana
    Recruiting

  • Conditions:   Pancreatic Cancer;   Thyroid Cancer;   Lung Cancer;   Esophageal Cancer;   Thymus Cancer;   Colon Cancer;   Rectal Cancer;   GIST;   Anal Cancer;   Bile Duct Cancer;   Duodenal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Small Intestine Cancer;   Peritoneal Surface Malignancies;   Familial Adenomatous Polyposis;   Lynch Syndrome;   Bladder Cancer;   Kidney Cancer;   Penile Cancer;   Prostate Cancer;   Testicular Cancer;   Ureter Cancer;   Urethral Cancer;   Hypopharyngeal Cancer;   Laryngeal Cancer;   Lip Cancer;   Oral Cavity Cancer;   Nasopharyngeal Cancer;   Oropharyngeal Cancer;   Paranasal Sinus Cancer;   Nasal Cavity Cancer;   Salivary Gland Cancer;   Skin Cancer;   CNS Tumor;   CNS Cancer;   Mesothelioma;   Breastcancer;   Leukemia;   Melanoma;   Sarcoma;   Unknown Primary Tumor;   Multiple Myeloma;   Ovarian Cancer;   Endometrial Cancer;   Vaginal Cancer
    Intervention:  
    Sponsor:   University of Nebraska
    Recruiting

  • Conditions:   Cancer of Pancreas;   Cancer of Liver;   Cancer of Rectum;   Cancer of Colon;   Cancer, Gall Bladder;   Myeloma Multiple;   Glioblastoma Multiforme
    Interventions:   Drug: Cannabidiol;   Drug: Bortezomib;   Drug: Leucovorin;   Drug: 5-FU;   Drug: Oxaliplatin;   Drug: Bevacizumab;   Drug: Irinotecan;   Drug: Gemcitabine;   Drug: Temozolomide
    Sponsor:   Leaf Vertical Inc.
    Not yet recruiting

  • Conditions:   Acute Cholecystitis;   Gangrenous Cholecystitis
    Interventions:   Procedure: Laparoscopic cholecystectomy with the implementation of modified ERAS program;   Procedure: Laparoscopic cholecystectomy with standard perioperative treatment
    Sponsor:   Pirogov Russian National Research Medical University
    Recruiting

  • Condition:   Chronic Calculous Cholecystitis
    Intervention:   Procedure: laparoscopic cholecystectomy
    Sponsor:   Assiut University
    Not yet recruiting

  • Condition:   Cholecystitis
    Intervention:   Device: medical device with CE marking (Ultravision ©)
    Sponsor:   Assistance Publique Hopitaux De Marseille
    Not yet recruiting

  • Conditions:   Cholecystitis, Acute;   Cholecystitis, Chronic
    Interventions:   Drug: BDD with UDCA;   Drug: Placebo
    Sponsor:   Ewha Womans University Mokdong Hospital
    Recruiting

  • Condition:   Cholecystitis, Acute
    Interventions:   Procedure: Ultrasonically activated scalpel;   Procedure: Electrocautery
    Sponsor:   Karolinska Institutet
    Not yet recruiting

  • Condition:   Cholecystitis, Acute
    Interventions:   Procedure: Gallbladder aspiration;   Procedure: Cholecystostomy
    Sponsor:   Karolinska Institutet
    Not yet recruiting

  • Condition:   Cholecystitis, Acute
    Interventions:   Procedure: Laparoscopic cholecystectomy;   Procedure: Non-operative treatment
    Sponsors:   Kuopio University Hospital;   Turku University Hospital;   Tampere University Hospital;   Oulu University Hospital;   Mikkeli Central Hospital;   North Karelia Central Hospital;   Jyväskylä Central Hospital;   Päijänne Tavastia Central Hospital;   Central Hospital of Hämeenlinna;   Central Hospital of Jorvi
    Recruiting

  • Conditions:   Biliary Disease;   Pancreatitis;   Gastrointestinal Neoplasms
    Intervention:   Other: clinical course
    Sponsor:   University of Southern California
    Recruiting

  • Condition:   Success Rate
    Interventions:   Procedure: Endoscopic naso-gallbladder drainage;   Procedure: Percutaneous gallbladder drainage
    Sponsor:   Hepatopancreatobiliary Surgery Institute of Gansu Province
    Recruiting

  • Conditions:   Acinar Cell Carcinoma;   Adenoid Cystic Carcinoma;   Adrenal Cortex Carcinoma;   Adrenal Gland Pheochromocytoma;   Anal Canal Neuroendocrine Carcinoma;   Anal Canal Undifferentiated Carcinoma;   Angiosarcoma;   Apocrine Neoplasm;   Appendix Mucinous Adenocarcinoma;   Bartholin Gland Transitional Cell Carcinoma;   Basal Cell Carcinoma;   Bladder Adenocarcinoma;   Cervical Adenocarcinoma;   Cervical Clear Cell Adenocarcinoma;   Cholangiocarcinoma;   Chordoma;   Colorectal Squamous Cell Carcinoma;   Desmoid-Type Fibromatosis;   Endometrial Transitional Cell Carcinoma;   Endometrioid Adenocarcinoma;   Esophageal Neuroendocrine Carcinoma;   Esophageal Undifferentiated Carcinoma;   Extrahepatic Bile Duct Carcinoma;   Extramammary Paget Disease;   Fallopian Tube Adenocarcinoma;   Fallopian Tube Transitional Cell Carcinoma;   Fibromyxoid Tumor;   Gallbladder Carcinoma;   Gastric Neuroendocrine Carcinoma;   Gastric Squamous Cell Carcinoma;   Gastric Undifferentiated Carcinoma;   Gastrointestinal Stromal Tumor;   Gestational Trophoblastic Tumor;   Giant Cell Carcinoma;   Intestinal Neuroendocrine Carcinoma;   Intrahepatic Cholangiocarcinoma;   Lung Carcinoid Tumor;   Lung Sarcomatoid Carcinoma;   Major Salivary Gland Carcinoma;   Malignant Odontogenic Neoplasm;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Testicular Sex Cord-Stromal Tumor;   Metaplastic Breast Carcinoma;   Metastatic Malignant Neoplasm of Unknown Primary;   Minimally Invasive Lung Adenocarcinoma;   Mixed Mesodermal (Mullerian) Tumor;   Mucinous Adenocarcinoma;   Mucinous Cystadenocarcinoma;   Nasal Cavity Adenocarcinoma;   Nasal Cavity Carcinoma;   Nasopharyngeal Carcinoma;   Nasopharyngeal Papillary Adenocarcinoma;   Nasopharyngeal Undifferentiated Carcinoma;   Oral Cavity Carcinoma;   Oropharyngeal Undifferentiated Carcinoma;   Ovarian Adenocarcinoma;   Ovarian Clear Cell Adenocarcinoma;   Ovarian Germ Cell Tumor;   Ovarian Mucinous Adenocarcinoma;   Ovarian Squamous Cell Carcinoma;   Ovarian Transitional Cell Carcinoma;   Pancreatic Acinar Cell Carcinoma;   Pancreatic Neuroendocrine Carcinoma;   Paraganglioma;   Paranasal Sinus Adenocarcinoma;   Paranasal Sinus Carcinoma;   Parathyroid Gland Carcinoma;   PEComa;   Peritoneal Mesothelioma;   Pituitary Gland Carcinoma;   Placental Choriocarcinoma;   Primary Peritoneal High Grade Serous Adenocarcinoma;   Pseudomyxoma Peritonei;   Rare Disorder;   Scrotal Squamous Cell Carcinoma;   Seminal Vesicle Adenocarcinoma;   Seminoma;   Serous Cystadenocarcinoma;   Small Intestinal Adenocarcinoma;   Small Intestinal Squamous Cell Carcinoma;   Spindle Cell Neoplasm;   Squamous Cell Carcinoma of the Penis;   Teratoma With Somatic-type Malignancy;   Testicular Non-Seminomatous Germ Cell Tumor;   Thyroid Gland Carcinoma;   Tracheal Carcinoma;   Transitional Cell Carcinoma;   Ureter Adenocarcinoma;   Ureter Squamous Cell Carcinoma;   Urethral Adenocarcinoma;   Urethral Squamous Cell Carcinoma;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma, Not Otherwise Specified;   Vulvar Carcinoma
    Interventions:   Procedure: Biospecimen Collection;   Biological: Ipilimumab;   Biological: Nivolumab
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Biliary Stones
    Interventions:   Device: DSC;   Device: ERC
    Sponsor:   Boston Scientific Corporation
    Recruiting

  • Conditions:   Cholecystolithiasis;   Cholecystitis
    Interventions:   Device: Laparoscopic Fluorescence Imaging System (Karl Storz);   Other: Indocyanine Green
    Sponsor:   Maastricht University Medical Center
    Recruiting

  • Condition:   Gallstones
    Intervention:   Other: Electro-acupuncture
    Sponsors:   Chinese University of Hong Kong;   Food and Health Bureau, Hong Kong
    Recruiting

  • Conditions:   Cholelithiases;   Cholecystolithiasis
    Interventions:   Device: Endotracheal tube (ETT);   Device: ProSeal Laryngeal Mask Airway (PLMA)
    Sponsor:   Sir Ganga Ram Hospital
    Recruiting

  • Condition:   Cholangiopancreatography, Endoscopic Retrograde
    Interventions:   Procedure: long duration EPBD;   Procedure: EST
    Sponsors:   Dankook University;   Inje University;   The Catholic University of Korea;   Wonkwang University
    Recruiting

  • Condition:   Biliary Stones
    Interventions:   Device: Spyglass DS cholangioscope;   Device: BML
    Sponsor:   Chinese University of Hong Kong
    Recruiting

  • Condition:   Cholecystolithiasis
    Intervention:   Device: Ultrasonic tissue coagulation dissection
    Sponsor:   Karolinska Institutet
    Recruiting

  • Conditions:   Biliary Obstruction;   Biliary Stones
    Intervention:   Procedure: Goff trans-pancreatic septotomy vs. Double wire technique
    Sponsor:   Subhas Banerjee
    Recruiting

  • Conditions:   Cholecystitis;   Vomiting;   Nausea
    Interventions:   Other: stimulation;   Other: no stimulation
    Sponsor:   Universitair Ziekenhuis Brussel
    Recruiting

  • Conditions:   Biliary Disease;   Gallstone; Cholecystitis, Acute;   Diverticulitis, Colonic;   Abscess Pelvic
    Interventions:   Diagnostic Test: Point of Care Ultrasound by Surgeons (POCUSS);   Diagnostic Test: Radiology report;   Procedure: Surgery-Intra-operative findings
    Sponsors:   Connolly Hospital Blanchardstown;   Royal College of Surgeons, Ireland;   Modular UltraSound ESTES Course (MUSEC);   European Socierty for Trauma and Emergency Surgery
    Recruiting

  • Condition:   Gallstone Disease
    Interventions:   Procedure: Cholecystectomy and intraoperative cholangiography;   Procedure: Magnet resonance cholangio-pancreaticography;   Device: magnet resonance imaging;   Device: catheter
    Sponsors:   University Hospital, Basel, Switzerland;   Clinical Trial Unit, University Hospital Basel, Switzerland
    Recruiting

  • Condition:   Cholecystitis; Acute, Choledocholithiasis
    Intervention:   Diagnostic Test: magnetic resonance cholangiopancreatography (MRCP)
    Sponsors:   Perspectum Diagnostics Ltd;   Oxford University Hospitals NHS Trust
    Not yet recruiting

  • Conditions:   Music Therapy;   Cholecystitis/Cholelithiasis;   Inflammatory Response;   Surgical Injury
    Intervention:   Other: Preoperative application of a bluetooth enabled Headphones.
    Sponsor:   Sir Ganga Ram Hospital
    Recruiting

  • Condition:   Gallstone
    Intervention:   Other: No intervention, observational
    Sponsor:   Helsinki University Central Hospital
    Recruiting

  • Conditions:   Postoperative Pain;   Cholecystitis; Gallstone
    Interventions:   Procedure: Bilateral ESP Block;   Procedure: Unilateral ESP Block;   Device: Intravenous Morphine patient controlled analgesia device
    Sponsor:   Kocaeli University
    Recruiting

  • Condition:   Stone - Biliary
    Intervention:   Procedure: Saline irrigation
    Sponsor:   Hepatopancreatobiliary Surgery Institute of Gansu Province
    Recruiting

  • Condition:   Cholecystolithiasis and Thyroid Nodule
    Intervention:   Drug: Ringer's solution acetate
    Sponsor:   China Medical University, China
    Recruiting

  • Conditions:   Gallstone;   Cholangitis;   Cholangiocarcinoma;   Pancreatitis;   Pancreatic Ductal Adenocarcinoma
    Intervention:   Other: ultra-rapid acquisition of bile ducts images
    Sponsor:   IHU Strasbourg
    Recruiting

  • Conditions:   Pancreatic Cancer;   Cholangiocarcinoma;   Bile Duct Injury;   Choledochal Cyst;   Biliary Calculi
    Interventions:   Procedure: Magnetic Compressive Anastomosis;   Procedure: Manual Anastomosis
    Sponsors:   First Affiliated Hospital Xi'an Jiaotong University;   Health Science Center of Xi’an Jiaotong University;   Northwest Institute for Non-ferrous Metal Research
    Recruiting

  • Conditions:   Abdominal Pain;   Shoulder Pain;   Satisfaction;   Complication
    Intervention:  
    Sponsor:   Bakirkoy Dr. Sadi Konuk Research and Training Hospital
    Recruiting

  • Conditions:   Acute Appendicitis;   Acute Cholecystitis;   Acute Diverticulitis;   Post-operative Complications;   Acute Pancreatitis;   Perforated Gastro-duodenal Ulcers;   Adhesive Small Bowell Occlusion;   Colonic Neoplastic Emergencies;   Gynecological Emergencies;   Vascular Emergencies;   Intestinal Ischemia;   Abdominal Wall Hernia;   Foreign Bodies;   Caustic Ingestion
    Intervention:   Procedure: Emergency General Surgery
    Sponsors:   A.O. Ospedale Papa Giovanni XXIII;   World Society of Emergency Surgery
    Not yet recruiting

  • Condition:   Pancreatitis
    Interventions:   Procedure: Early cholecystectomy with IOC;   Procedure: Late cholecystectomy with IOC
    Sponsor:   The University of Texas Health Science Center, Houston
    Recruiting

  • Conditions:   Appendicitis;   Evidence of Cholecystectomy;   Gallstones;   Pregnancy, Ectopic;   Aortic Aneurysm;   Kidney Stones;   Intrauterine Pregnancy;   Diverticulitis;   Abdominal Injuries;   Tumors;   Pancreatitis;   Digestive System Diseases;   Gastrointestinal Diseases;   Intraabdominal Infections;   Intestinal Diseases;   Pregnancy;   Vascular Disease;   Uterine Fibroids;   Ovarian Cysts;   Uterine Abnominalies;   Bladder Abnominalies;   Testicular Abnominalies;   Polyps
    Intervention:  
    Sponsors:   Duke University;   Wallace H. Coulter Foundation
    Recruiting

  • Conditions:   Gastric Cancer;   Colorectal Cancer;   Pancreatic Cancer;   Biliary Cancer
    Intervention:   Biological: AbGn-107
    Sponsor:   AbGenomics B.V Taiwan Branch
    Recruiting